NCT06502561CompletedPhase 1
A study to compare two different aramchol formulations in healthy volunteers.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Dec 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 9 Sept 2024
- Start date
- 18 Dec 2024
- Lead sponsor
- CCDRD Cooperative Clinical Drug Research and Development AG
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06502561
- EU CT number
- 2023-507445-28-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 16
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bed space for short term stay at Diagnostic & Consultative Centre 'Ascendent' Ltd. Coordinator of this site? Confirm its status | Sofia | Bulgaria | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.